Imprint Wealth LLC boosted its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6,828.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 199,611 shares of the company’s stock after acquiring an additional 196,730 shares during the period. Colgate-Palmolive accounts for approximately 0.8% of Imprint Wealth LLC’s portfolio, making the stock its 2nd largest holding. Imprint Wealth LLC’s holdings in Colgate-Palmolive were worth $19,961,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Tucker Asset Management LLC bought a new stake in Colgate-Palmolive during the 1st quarter worth approximately $27,000. Register Financial Advisors LLC bought a new stake in Colgate-Palmolive during the first quarter valued at $30,000. Quarry LP grew its position in Colgate-Palmolive by 48.2% during the second quarter. Quarry LP now owns 446 shares of the company’s stock worth $34,000 after buying an additional 145 shares in the last quarter. Glass Jacobson Investment Advisors llc bought a new position in Colgate-Palmolive in the 2nd quarter worth about $36,000. Finally, West Tower Group LLC purchased a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at about $36,000. 78.36% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Down 0.4 %
Shares of NYSE CL traded down $0.31 during midday trading on Monday, hitting $75.27. The stock had a trading volume of 1,300,340 shares, compared to its average volume of 4,681,951. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $82.09. The company has a market cap of $61.98 billion, a P/E ratio of 39.36, a PEG ratio of 3.35 and a beta of 0.46. The business’s 50 day moving average is $72.90 and its 200-day moving average is $75.18. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 21.40.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were paid a dividend of $0.48 per share. The ex-dividend date was Friday, October 20th. This represents a $1.92 dividend on an annualized basis and a yield of 2.55%. Colgate-Palmolive’s dividend payout ratio is presently 100.00%.
Analyst Upgrades and Downgrades
A number of research firms have commented on CL. Citigroup cut their price target on shares of Colgate-Palmolive from $92.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, October 11th. Bank of America reduced their price target on shares of Colgate-Palmolive from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 17th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, October 30th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Colgate-Palmolive from $88.00 to $91.00 and gave the stock a “buy” rating in a report on Monday, July 31st. Finally, Stifel Nicolaus upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and cut their price objective for the stock from $85.00 to $81.00 in a research report on Monday, October 16th. Five equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $82.57.
In other news, insider John W. Kooyman sold 3,000 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $75.11, for a total transaction of $225,330.00. Following the completion of the sale, the insider now owns 5,347 shares of the company’s stock, valued at approximately $401,613.17. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider John W. Kooyman sold 3,000 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $75.11, for a total transaction of $225,330.00. Following the transaction, the insider now directly owns 5,347 shares in the company, valued at approximately $401,613.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Lorrie M. Norrington sold 6,329 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $74.56, for a total value of $471,890.24. Following the completion of the sale, the director now owns 31,307 shares in the company, valued at $2,334,249.92. The disclosure for this sale can be found here. Insiders have sold 93,153 shares of company stock valued at $6,851,466 in the last ninety days. 0.34% of the stock is currently owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
- Five stocks we like better than Colgate-Palmolive
- Why Invest in High-Yield Dividend Stocks?
- The most upgraded stocks in November have two things in common
- How to Invest in E-Commerce: A Guide
- Monday.com rocked earnings like it’s the weekend
- What is the S&P/TSX Index?
- Plan to own one retailer? Make it this one
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.